1 – 20 of 27
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
(
- Contribution to journal › Article
-
Mark
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
2017) In NeuroMolecular Medicine(
- Contribution to journal › Article
- 2016
-
Mark
Pro-inflammatory S100A9 Protein as a Robust Biomarker Differentiating Early Stages of Cognitive Impairment in Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology
(
- Contribution to journal › Article
-
Mark
Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
(
- Contribution to journal › Article
- 2015
-
Mark
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid substance P concentrations are elevated in patients with Alzheimer's disease
(
- Contribution to journal › Article
- 2014
-
Mark
The amyloid-β degradation pattern in plasma: A possible tool for clinical trials in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Increased levels of UCHL-1 in cerebrospinal fluid from patients with Alzheimer’s disease.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Endokrina och diagnostiska aspekter på kognitiv svikt
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
The ELISA-Measured Increase in Cerebrospinal Fluid Tau that Discriminates Alzheimer's Disease from other Neurodegenerative Disorders is not Attributable to Differential Recognition of Tau Assembly Forms
(
- Contribution to journal › Article
-
Mark
Endocrine and diagnostic aspects of cognitive impairment with special reference to Alzheimer's disease
2013)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Serum but not Cerebrospinal Fluid levels of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 (IGFBP-3) are Increased in Alzheimer ́s Disease
2013) Endokrindagarna, 2013(
- Contribution to conference › Poster
-
Mark
Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease
(
- Contribution to journal › Article
- 2012
-
Mark
The determination of aggregated tau in solution and its potential as a tool for the diagnosis of tauopathies
2012) 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) In European Journal of Neurology 19(Suppl. 1). p.98-98(
- Contribution to journal › Published meeting abstract
-
Mark
Leukocyte Telomere Length (LTL) is reduced in stable mild cognitive impairment but low LTL is not associated with conversion to Alzheimer's Disease: A pilot study
(
- Contribution to journal › Article
-
Mark
Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer´s disease
2012) Endokrindagarna, 2012(
- Contribution to conference › Other